MedCity News

MedCity News is a trusted source for healthcare innovation news and analysis for busy professionals and senior executives. As the healthcare industry undergoes an overall transformation with an intense focus on value-based care, MedCity News reports on how the healthcare ecosystem – payers, providers, healthtech startups, investors, medtech, diagnostics and biopharma companies — are striving towar

d that goal. We get beyond the press releases to tell you how health IT startups, artificial intelligence companies, life science companies and hospitals are reimagining care to improve outcomes and reduce costs in a variety of chronic diseases like heart failure and diabetes as well as in cancer. We explain the latest trends in remote patient monitoring and clinical workflows. MedCity News produces events that bring together the healthcare ecosystem and important stakeholders to share insights on challenges and opportunities in the industry. Check out our upcoming events here: https://events.medcitynews.com/. For healthcare startups, we have created the MedCitizens community. As a member, you will be featured on MedCityNews.com and be able to reach our newsletter audience with regular updates about your company. For experienced industry professionals and senior executives eager to showcase their thought leadership or a strong opinion, we have created the MedCity Influencers program. This outside contributors’ program is published on MedCityNews.com and circulated through our daily newsletter. Our daily newsletter reaches a senior industry audience and captures the news highlights of the day. Our weekly biopharma newsletter, BioPulse, is a weekly wrap of the most notable news in the industry in the week. Our StartUPDATES newsletter is focused on sharing news and updates from our MedCitizens. Sign up for our newsletters here: https://medcitynews.com/subscribe/.

Author Ronald Razmi’s hilarious take on how people react to the need for clinical evidence in AI applications in healthc...
13/01/2025

Author Ronald Razmi’s hilarious take on how people react to the need for clinical evidence in AI applications in healthcare.

Watch, follow, and discover more trending content.

Prioritize Provider Data for Seamless M&A Success
13/01/2025

Prioritize Provider Data for Seamless M&A Success

Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations.

AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive!
13/01/2025

AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive!

AI is the next big thing, and most developers want to protect those programs and systems. The answer is intellectual property protection and specifically patent protection.

Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target
13/01/2025

Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target

Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Con...

HHS’ Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply
12/01/2025

HHS’ Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply

HHS is proposing major changes to HIPAA for the first time in more than a decade, aiming to strengthen cybersecurity protocols for electronic health data. Healthcare cybersecurity leaders are mainly in favor of the proposal — though there are some concerns that smaller providers will struggle with...

Mental Health Data Sells, But Who’s Buying?
12/01/2025

Mental Health Data Sells, But Who’s Buying?

Implementing a thorough federal privacy law and broadening HIPAA protections to include new mHealth technologies are crucial steps in enhancing personal data security. Equally important, companies and developers should adhere to strict ethical standards and robust security protocols during app devel...

Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare
12/01/2025

Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare

AI holds a lot of promise in supporting employer-sponsored healthcare, including improving patient navigation and billing, according to a new report from Morgan Health.

When Algorithms Decide Who Lives and Who Suffers
12/01/2025

When Algorithms Decide Who Lives and Who Suffers

The choices we make now will determine not just the future of healthcare, but the kind of society we leave to our children. Will we continue to allow faceless algorithms to decide who lives and who suffers? Or will we finally reclaim healthcare's moral center and build a system worthy of our highest...

Why Hospitals’ Revenue Growth Is Likely to Slow Down in 2025
10/01/2025

Why Hospitals’ Revenue Growth Is Likely to Slow Down in 2025

Hospitals’ operating margins dropped in November due to decreased patient demand levels and continued increases in expenses, according to a new report. One healthcare expert noted that rising expenses will remain a major problem for hospitals throughout 2025.

5 Ways the Healthcare Industry Should Improve Youth Mental Health, Per BPC’s Task Force
10/01/2025

5 Ways the Healthcare Industry Should Improve Youth Mental Health, Per BPC’s Task Force

The Bipartisan Policy Center's Youth Mental Health and Substance Use Task Force recently released a report focused on redesigning the healthcare system to support youth mental health. Here are five key findings.

Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System
10/01/2025

Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System

Ouro Medicines’ drugs deplete disease-driving immune cells, allowing the immune system to reset with naïve cells that don’t attack the body. Monograph Capital founded the startup in partnership with GSK.

How Personalized Daily Rewards Close Care Gaps
10/01/2025

How Personalized Daily Rewards Close Care Gaps

When we meet members where they are — whether it’s helping them buy groceries or find transportation to a doctor’s appointment — we’re not just closing care gaps; we’re building trust.

Disrupting Legacy Systems: Preparing for the Next Generation of Health Tech
10/01/2025

Disrupting Legacy Systems: Preparing for the Next Generation of Health Tech

Today's patients want and deserve a more efficient and high-tech experience and the next generation of providers are no different. These upgrades can improve our productivity and enhance the quality of our patients' lives.

Innovaccer Rakes In $275M, Kicking Off What Will Likely Be Another Hot Year for AI Funding
10/01/2025

Innovaccer Rakes In $275M, Kicking Off What Will Likely Be Another Hot Year for AI Funding

Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 million. The company has plans to go public “at some point,” but it isn’t in any hurry, said CEO Abhinav Shashank.

It’s the week before the annual JPM healthcare conference. What is the most interesting healthcare Pre-JPM news so far?
09/01/2025

It’s the week before the annual JPM healthcare conference. What is the most interesting healthcare Pre-JPM news so far?

Watch, follow, and discover more trending content.

Twentyeight Health Raises $10M, Secures New Medicaid Partnerships
09/01/2025

Twentyeight Health Raises $10M, Secures New Medicaid Partnerships

Twentyeight Health's $10 million Series A round was led by Seae Ventures and included participation from Impact America Fund, The Social Entrepreneurs' Fund, RH Capital, Impact Engine, Gratitude Railroad and Townhall Ventures.

Metabolic Meds Startup Verdiva Launches With $411M and a Weekly Oral GLP-1 Drug
09/01/2025

Metabolic Meds Startup Verdiva Launches With $411M and a Weekly Oral GLP-1 Drug

Verdiva Bio’s once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences.

What AI Can Do for Pharmacist Burnout
09/01/2025

What AI Can Do for Pharmacist Burnout

AI offers a number of immediate opportunities for pharmacies to change their operation through intelligent automation, freeing up pharmacists to provide their patient population with higher-value services like patient counseling and medication management.

Address


Alerts

Be the first to know and let us send you an email when MedCity News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MedCity News:

Videos

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Videos
  • Claim ownership or report listing
  • Want your business to be the top-listed Media Company?

Share

About Us

• MedCity News is the leading web destination for the healthcare executive community covering the latest innovations in healthcare and venture capital investment.

• The company also hosts executive healthcare conferences nationwide, attended by executives from leading providers, life sciences companies, payers, startups and investors in healthcare

Read more at www.medcitynews.com